• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响仿制药产品生命周期的因素。

Factors Affecting the Product Life Cycle of Generic Medicines.

作者信息

Mousavi Atefeh, Zare Hossein, Asadian Aydin, Mohammadzadeh Mehdi

机构信息

Pharmaceutical and Health Economics and Management Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Health Policy and Management, Johns Hopkins Center for Health Disparities Solutions, the University of Maryland Global Campus, Health Services Management, 624 North Broadway, Baltimore, Maryland, United States.

出版信息

Iran J Pharm Res. 2022 Apr 29;21(1):e127039. doi: 10.5812/ijpr-127039. eCollection 2022 Dec.

DOI:10.5812/ijpr-127039
PMID:36060917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9420220/
Abstract

BACKGROUND

Product life cycle (PLC) refers to the time ranging from when a product is introduced into the market to when it is taken off the shelves. The PLC management can guarantee product survival and prevent its decline.

OBJECTIVES

This study investigated generic antibiotic PLCs and detected factors affecting them in the competitive pharmaceutical market of Iran to improve the PLC management of such drugs.

METHODS

To study the PLC of antibiotics, data were collected from 2002 to 2017, and then the PLC curves were analyzed. Accordingly, factors affecting the PLC of antibiotics were illustrated in two sections: all PLC curves and the PLC curves with one sales peak. Using a generalized linear model combined with a machine learning approach, we identified the sales patterns and the effect of the product-related and the competition-related factors on the PLC curves, peak height, and the time to reach peak sales.

RESULTS

According to the findings, 16, 11.87, 13.03, and 59% of the antibiotics had linear, binomial, one-peak, and oscillating sales patterns, respectively. The most crucial factors affecting the PLC shape were the quality, microbial spectrum, dosage forms, number of competitors, and entry arrangement.

CONCLUSIONS

This study examined factors affecting the PLC patterns of generic pharmaceutical products. The findings would provide more insights into the generic pharmaceutical market as one of the less-studied markets in many countries.

摘要

背景

产品生命周期(PLC)是指产品从进入市场到下架的时间跨度。产品生命周期管理能够确保产品存续并防止其衰退。

目的

本研究调查了伊朗竞争激烈的药品市场中通用抗生素的产品生命周期,并检测了影响其的因素,以改善此类药物的产品生命周期管理。

方法

为研究抗生素的产品生命周期,收集了2002年至2017年的数据,然后对产品生命周期曲线进行分析。据此,从两个方面阐述了影响抗生素产品生命周期的因素:所有产品生命周期曲线以及具有一个销售峰值的产品生命周期曲线。使用广义线性模型结合机器学习方法,我们确定了销售模式以及产品相关和竞争相关因素对产品生命周期曲线、峰值高度和达到销售峰值时间的影响。

结果

根据研究结果,分别有16%、11.87%、13.03%和59%的抗生素具有线性、二项式、单峰和振荡销售模式。影响产品生命周期形状的最关键因素是质量、微生物谱、剂型、竞争对手数量和进入安排。

结论

本研究考察了影响通用药品产品生命周期模式的因素。这些发现将为许多国家较少研究的市场之一——通用药品市场提供更多见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/6aae3616bb69/ijpr-21-1-127039-i004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/9ebf24b2ecf8/ijpr-21-1-127039-i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/ad55e2c0e189/ijpr-21-1-127039-i002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/cfd5fcd48ce4/ijpr-21-1-127039-i003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/6aae3616bb69/ijpr-21-1-127039-i004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/9ebf24b2ecf8/ijpr-21-1-127039-i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/ad55e2c0e189/ijpr-21-1-127039-i002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/cfd5fcd48ce4/ijpr-21-1-127039-i003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5275/9420220/6aae3616bb69/ijpr-21-1-127039-i004.jpg

相似文献

1
Factors Affecting the Product Life Cycle of Generic Medicines.影响仿制药产品生命周期的因素。
Iran J Pharm Res. 2022 Apr 29;21(1):e127039. doi: 10.5812/ijpr-127039. eCollection 2022 Dec.
2
The diffusion of generics after patent expiry in Germany.德国专利到期后仿制药的扩散情况。
Eur J Health Econ. 2016 Nov;17(8):1027-1040. doi: 10.1007/s10198-015-0744-3. Epub 2015 Nov 16.
3
The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia.报销政策对斯洛伐克非专利药品市场的影响。
Front Pharmacol. 2021 Dec 13;12:795002. doi: 10.3389/fphar.2021.795002. eCollection 2021.
4
Does the market share of generic medicines influence the price level?: a European analysis.仿制药的市场份额是否会影响价格水平?:一项欧洲分析。
Pharmacoeconomics. 2011 Oct;29(10):875-82. doi: 10.2165/11585970-000000000-00000.
5
The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland.仿制药替代对制药公司活动的影响——从公司角度对芬兰引入仿制药替代一年及五年后的调查。
BMC Clin Pharmacol. 2010 Oct 22;10:15. doi: 10.1186/1472-6904-10-15.
6
Measuring performance in off-patent drug markets: a methodological framework and empirical evidence from twelve EU Member States.衡量专利过期药品市场的绩效:一个方法框架及来自十二个欧盟成员国的实证证据。
Health Policy. 2014 Nov;118(2):229-41. doi: 10.1016/j.healthpol.2014.08.005. Epub 2014 Aug 27.
7
The Brazilian private pharmaceutical market after the first ten years of the generics law.仿制药法实施十年后的巴西私营制药市场。
J Pharm Policy Pract. 2019 Aug 14;12:18. doi: 10.1186/s40545-019-0179-9. eCollection 2019.
8
Impact of European pharmaceutical price regulation on generic price competition: a review.欧洲药品价格管制对仿制药价格竞争的影响:综述。
Pharmacoeconomics. 2010;28(8):649-63. doi: 10.2165/11535360-000000000-00000.
9
Recent trends in brand-name and generic drug competition.近年来品牌药和仿制药的竞争趋势。
J Med Econ. 2014 Mar;17(3):207-14. doi: 10.3111/13696998.2013.873723. Epub 2013 Dec 23.
10
Updated trends in US brand-name and generic drug competition.美国品牌药与仿制药竞争的最新趋势。
J Med Econ. 2016 Sep;19(9):836-44. doi: 10.1080/13696998.2016.1176578. Epub 2016 Apr 20.

本文引用的文献

1
Using machine-learning methods to support health-care professionals in making admission decisions.利用机器学习方法为医疗保健专业人员提供支持,以帮助他们做出入院决策。
Int J Health Plann Manage. 2019 Apr;34(2):e1236-e1246. doi: 10.1002/hpm.2769. Epub 2019 Apr 7.
2
An Investigation of Prescription Indicators and Trends Among General Practitioners and Specialists From 2005 to 2015 in Kerman, Iran.伊朗克尔曼 2005 年至 2015 年全科医生和专科医生处方指标及趋势调查
Int J Health Policy Manag. 2018 Sep 1;7(9):818-827. doi: 10.15171/ijhpm.2018.28.
3
Mixed effect machine learning: A framework for predicting longitudinal change in hemoglobin A1c.
混合效应机器学习:预测血红蛋白 A1c 纵向变化的框架。
J Biomed Inform. 2019 Jan;89:56-67. doi: 10.1016/j.jbi.2018.09.001. Epub 2018 Sep 4.
4
Prescribing patterns and associated factors of antibiotic prescription in primary health care facilities of Kumbo East and Kumbo West Health Districts, North West Cameroon.喀麦隆西北省孔波伊东和孔波伊西卫生区初级卫生保健机构抗生素处方的开具模式及相关因素。
PLoS One. 2018 Mar 5;13(3):e0193353. doi: 10.1371/journal.pone.0193353. eCollection 2018.
5
Trends in Iran Pharmaceutical Market.伊朗制药市场趋势
Iran J Pharm Res. 2017 Winter;16(1):1-7.
6
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data.全球抗生素消费 2000 年至 2010 年:国家药品销售数据分析。
Lancet Infect Dis. 2014 Aug;14(8):742-750. doi: 10.1016/S1473-3099(14)70780-7. Epub 2014 Jul 9.
7
OriginPro 9.1: scientific data analysis and graphing software-software review.OriginPro 9.1:科学数据分析与绘图软件——软件评测
J Chem Inf Model. 2014 May 27;54(5):1552. doi: 10.1021/ci500161d. Epub 2014 Apr 25.
8
A system dynamics model for national drug policy.国家药物政策的系统动力学模型。
Daru. 2014 Apr 1;22(1):34. doi: 10.1186/2008-2231-22-34.
9
Trend analysis of the pharmaceutical market in Iran; 1997-2010; policy implications for developing countries.伊朗医药市场趋势分析;1997-2010 年;对发展中国家的政策启示。
Daru. 2013 Jun 28;21(1):52. doi: 10.1186/2008-2231-21-52.
10
Evergreening, patent challenges, and effective market life in pharmaceuticals.药品的专利常青、专利挑战和有效市场寿命。
J Health Econ. 2012 Mar;31(2):327-39. doi: 10.1016/j.jhealeco.2012.01.004. Epub 2012 Feb 9.